Curaleaf Holdings reported a stable third quarter with $320 million in revenue, showcasing resilience amidst price compression while achieving significant growth in its international segment.

• Revenue increased by 2% sequentially, with the international segment experiencing robust 12% sequential growth and 56% year-over-year growth.
• Adjusted gross margins improved to 50%, reflecting a 115 basis point increase, while adjusted EBITDA stood at $69 million, yielding a 22% margin.
• The company strengthened its balance sheet by closing a $100 million revolving credit line, providing enhanced operational flexibility.
• Average flower potency surpassed 30% for the first time, aided by improved cultivation techniques and genetics.
• The launch of innovative products such as the Anthem pre-roll brand is gaining traction, significantly contributing to sales and brand awareness.